Abstract
Synaptic loss is the best pathological correlate of the cognitive decline in Alzheimer's disease; however, the molecular mechanisms underlying synaptic failure are unknown. We found a non-apoptotic baseline caspase-3 activity in hippocampal dendritic spines and an enhancement of this activity at the onset of memory decline in the Tg2576-APPswe mouse model of Alzheimer's disease. In spines, caspase-3 activated calcineurin, which in turn triggered dephosphorylation and removal of the GluR1 subunit of AMPA-type receptor from postsynaptic sites. These molecular modifications led to alterations of glutamatergic synaptic transmission and plasticity and correlated with spine degeneration and a deficit in hippocampal-dependent memory. Notably, pharmacological inhibition of caspase-3 activity in Tg2576 mice rescued the observed Alzheimer-like phenotypes. Our results identify a previously unknown caspase-3–dependent mechanism that drives synaptic failure and contributes to cognitive dysfunction in Alzheimer's disease. These findings indicate that caspase-3 is a potential target for pharmacological therapy during early disease stages.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arendt, T. Synaptic degeneration in Alzheimer′s disease. Acta Neuropathol. 118, 167–179 (2009).
Morrison, J.H. & Hof, P.R. Life and death of neurons in the aging brain. Science 278, 412–419 (1997).
Bookheimer, S.Y. et al. Patterns of brain activation in people at risk for Alzheimer′s disease. N. Engl. J. Med. 343, 450–456 (2000).
Elias, M.F. et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch. Neurol. 57, 808–813 (2000).
Zhou, Y. et al. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment. Alzheimers Dement. 4, 265–270 (2008).
Scheff, S.W., Price, D.A., Schmitt, F.A., DeKosky, S.T. & Mufson, E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501–1508 (2007).
Bourne, J.N. & Harris, K.M. Balancing structure and function at hippocampal dendritic spines. Annu. Rev. Neurosci. 31, 47–67 (2008).
Ferrer, I., Guionnet, N., Cruz-Sánchez, F. & Tuñón, T. Neuronal alterations in patients with dementia: a Golgi study on biopsy samples. Neurosci. Lett. 114, 11–16 (1990).
Lanz, T.A., Carter, D.B. & Merchant, K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13, 246–253 (2003).
Mattson, M.P., Keller, J.N. & Begley, J.G. Evidence for synaptic apoptosis. Exp. Neurol. 153, 35–48 (1998).
Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
Jacobsen, J.S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer′s disease. Proc. Natl. Acad. Sci. USA 103, 5161–5166 (2006).
Kawarabayashi, T. et al. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer′s disease. J. Neurosci. 21, 372–381 (2001).
Irizarry, M.C., McNamara, M., Fedorchak, K., Hsiao, K. & Hyman, B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965–973 (1997).
Westerman, M.A. et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer′s disease. J. Neurosci. 22, 1858–1867 (2002).
Janus, C. et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer′s disease. Nature 408, 979–982 (2000).
Chen, G. et al. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer′s disease. Nature 408, 975–979 (2000).
Phillips, R.G. & LeDoux, J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274–285 (1992).
Lee, I. & Kesner, R.P. Differential contributions of dorsal hippocampal subregions to memory acquisition and retrieval in contextual fear-conditioning. Hippocampus 14, 301–310 (2004).
Lajtha, A., Perez-Polo, J.R. & Rossner, S. Handbook of Neurochemistry and Molecular Neurobiology (Springer, New York, 2008).
Li, S. et al. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788–801 (2009).
Almeida, C.G. et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20, 187–198 (2005).
Malinow, R. & Malenka, R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25, 103–126 (2002).
Chapman, P.F. et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271–276 (1999).
Lee, H.K., Kameyama, K., Huganir, R.L. & Bear, M.F. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron 21, 1151–1162 (1998).
van Engeland, M., Nieland, L.J., Ramaekers, F.C., Schutte, B. & Reutelingsperger, C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1–9 (1998).
Green, D.R. & Kroemer, G. The pathophysiology of mitochondrial cell death. Science 305, 626–629 (2004).
Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S. & Peter, M.E. Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439–459 (1998).
Hsieh, H. et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831–843 (2006).
Mukerjee, N., McGinnis, K.M., Park, Y.H., Gnegy, M.E. & Wang, K.K. Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. Arch. Biochem. Biophys. 379, 337–343 (2000).
Vicent, M.J. & Pérez-Payá, E. Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine. J. Med. Chem. 49, 3763–3765 (2006).
Santamaría, B. et al. A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury. PLoS ONE 4, e6634 (2009).
Salvesen, G.S. & Dixit, V.M. Caspases: intracellular signaling by proteolysis. Cell 91, 443–446 (1997).
Bravarenko, N.I. et al. Caspase-like activity is essential for long-term synaptic plasticity in the terrestrial snail Helix. Eur. J. Neurosci. 23, 129–140 (2006).
Huesmann, G.R. & Clayton, D.F. Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation. Neuron 52, 1061–1072 (2006).
Li, Z. et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 141, 859–871 (2010).
Marín, N. et al. Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons. Mech. Ageing Dev. 119, 63–67 (2000).
Gervais, F.G. et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97, 395–406 (1999).
Stadelmann, C. et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am. J. Pathol. 155, 1459–1466 (1999).
Louneva, N. et al. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer′s disease. Am. J. Pathol. 173, 1488–1495 (2008).
Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368–372 (1996).
Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339–352 (1998).
Kuida, K. et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325–337 (1998).
Cecconi, F., Alvarez-Bolado, G., Meyer, B.I., Roth, K.A. & Gruss, P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94, 727–737 (1998).
Takahashi, R.H. et al. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 3592–3599 (2004).
Manczak, M. et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437–1449 (2006).
Cho, D.H. et al. S-nytrosylation of Drp1 mediates beta-amyloid–related mitochondrial fission and neuronal injury. Science 324, 102–105 (2009).
Marie, H., Morishita, W., Yu, X., Calakos, N. & Malenka, R.C. Generation of silent synapses by acute in vivo expression of CaMKIV and CREB. Neuron 45, 741–752 (2005).
Gylys, K.H., Fein, J.A., Wiley, D.J. & Cole, G.M. Rapid annexin-V labeling in synaptosomes. Neurochem. Int. 44, 125–131 (2004).
Ferri, A. et al. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase. J. Neurochem. 75, 606–613 (2000).
Acknowledgements
We thank the Animal Facility of the IRCCS Fondazione Santa Lucia/EBRI/CNR for the mouse work, Taconic for the Tg2576 mice, M. Acuña-Villa and M.W. Bennett for editorial and secretarial work, R. Nardacci, F. Fanelli and M. Nencini for research assistance and help with image processing, and A. Roberto and A. Pignataro for help with Neurolucida measurements. We are grateful to E. Pérez-Payá for providing us with the apoptosome inhibitor QM56. This work was supported in part by grants from the Telethon Foundation, Ricerca Corrente and Ricerca Finalizzata from the Italian Ministry of Health, the Italian Ministry of University and Research and Compagnia di San Paolo.
Author information
Authors and Affiliations
Contributions
M.D. and V.C. designed and carried out all of the molecular biology experiments and caspase-3 analysis. V.C. helped write the manuscript. S. Middei and M.A.-T. performed behavioral and dendritic spine analysis. S. Middei performed surgery. A.B. and S.P. performed LTP analysis. H.M. and C.M. performed patch-clamp and LTD experiments. A.F. carried out calcineurin activity assays. S. Moreno and P.C. performed immunoelectron microscopy analysis. L.B. and A.D. performed fluorescence-activated cell-sorting analysis. D.D.Z. analyzed the oxidative stress. M.D. and F.C. conceived and designed the study, supervised all of the experiments and wrote the manuscript. All of the authors discussed the results and commented on the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–23 (PDF 2872 kb)
Rights and permissions
About this article
Cite this article
D'Amelio, M., Cavallucci, V., Middei, S. et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 14, 69–76 (2011). https://doi.org/10.1038/nn.2709
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2709